Myocardial 123I-MIBG scintigraphy predicts an impairment in myocardial functional reserve during dobutamine stress in patients with idiopathic dilated cardiomyopathy

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 40, Issue 2, 2013, Pages 262-270

  Ohshima, Satoru ^a,b   Isobe, Satoshi ^a   Hayashi, Daisuke ^a   Abe, Shinji ^c   Kato, Katsuhiko ^a   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Tsushima City Hospital   (Japan)

^c NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Dobutamine stress test; Idiopathic dilated cardiomyopathy; Myocardial 123I metaiodobenzylguanidine scintigraphy; Myocardial functional reserve

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; DOBUTAMINE; BETA ADRENERGIC RECEPTOR; RADIOACTIVE IODINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; DENERVATION; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE PRESSURE; HUMAN; MALE; MYOCARDIAL PERFUSION IMAGING; PATIENT CODING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; EXERCISE TEST; HEART; HEART MUSCLE; HEART RATE; HEART VENTRICLE; MEDIASTINUM; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

ADULT; CARDIAC CATHETERIZATION; CARDIOMYOPATHY, DILATED; DOBUTAMINE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART; HEART RATE; HEART VENTRICLES; HUMANS; IODINE RADIOISOTOPES; MALE; MEDIASTINUM; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; RADIONUCLIDE IMAGING; RECEPTORS, ADRENERGIC, BETA;

MLCS; MLOWN;

EID: 84874107488     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2256-z     Document Type: Article

References (23)

1. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 1981;47:525-31.
2. Kelly DP, Strawss AW. Inherited cardiomyopathies. N Engl J Med. 1994;330:913-9.
3. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med. 1991;325:293-302.
4. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349-55.
5. Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, et al. Effect of losartan compared with captopril on mortality in patients with heart failure: randomized trial - the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000;355:1582-7.
6. Pratali L, Picano E, Otasevic P, Vigna C, Palinkas A, Cortigiani L, et al. Prognostic significance of the dobutamine echocardiography test in idiopathic dilated cardiomyopathy. Am J Cardiol. 2001;88:1374-8.
7. Pratali L, Otasevic P, Neskovic A, Molinaro S, Picano E. Prognostic value of pharmacological stress echocardiography in patients with idiopathic dilated cardiomyopathy: a prospective, head-to-head comparison between dipyridamole and dobutamine test. J Card Fail. 2007;13:836-42.
8. Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine in patients with heart failure. J Nucl Med. 1992;33:471-7.
9. Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Randé JL, Duval AM, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med. 1999;40:917-23.
10. Gerson MC, McGuire N, Wagoner LE. Sympathetic nervous system function as measured by I-123 metaiodobenzylguanidine predicts transplant-free survival in heart failure patients with idiopathic dilated cardiomyopathy. J Card Fail. 2003;9:384-91.
11. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55:2212-21.
12. Ohshima S, Isobe S, Izawa H, Nanasato M, Ando A, Yamada A, et al. Cardiac sympathetic dysfunction correlates with abnormal myocardial contractile reserve in dilated cardiomyopathy. J Am Coll Cardiol. 2005;46:2061-8.
13. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270-6.
14. Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jacques Jr S. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med. 1987;28:1620-4.
15. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-67.
16. Kobayashi M, Izawa H, Cheng XW, Asano H, Hirashiki A, Unno K, et al. Dobutamine stress testing as a diagnostic tool for evaluation of myocardial contractile reserve in asymptomatic or mildly symptomatic patients with dilated cardiomyopathy. JACC Cardiovasc Imaging. 2008;1:718-26.
17. Hirashiki A, Izawa H, Cheng XW, Unno K, Ohshima S, Murohara T. Dobutamine-induced mechanical alternans is a marker of poor prognosis in idiopathic dilated cardiomyopathy. Clin Exp Pharmacol Physiol. 2010;37:1004-9.
18. Suwa M, Otake Y, Moriguchi A, Ito T, Hirota Y, Kawamura K, et al. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy. Am Heart J. 1997;133:353-8.
19. 123I iodobenzylguanidine myocardial scintigraphy for predicting cardiac events in patients with dilated cardiomyopathy. Nucl Med Commun. 2005;26:97-102.
20. Fukuoka S, Hayashida K, Hirose Y, Shimotsu Y, Ishida Y, Kakuchi H, et al. Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of beta-blocker therapy in patients with dilated cardiomyopathy. Eur J Nucl Med. 1997;24:523-9.
21. Kakuchi H, Sasaki T, Ishida Y, Komamura K, Miyatake K. Clinical usefulness of 123I-meta-iodobenzylguanidine imaging in predicting the effectiveness of beta blockers for patients with idiopathic dilated cardiomyopathy before and soon after treatment. Heart. 1999;81:148-52.
22. Kawano H, Okada R, Yano K. Histological study on the distribution of autonomic nerves in the human heart. Heart Vessels. 2003;18:32-9.
23. 2 slope. Int J Cardiol. 2011; Epub ahead of print. doi: 10.1016/j.ijcard.2011.05.065